Initial prostate biopsy: Development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay Academic Article uri icon

Overview

MeSH Major

  • Antigens, Neoplasm
  • Nomograms
  • Prostate
  • Prostatic Neoplasms

abstract

  • The internally validated PCA3-based IBX-specific nomogram outperforms a clinical prediction model without PCA3 for the prediction of any PCa, leading to the avoidance of unnecessary biopsies while missing only a few cases of HGPCa. Our findings support the concepts of a combination of novel markers with established clinical risk factors and the superiority of decision tools that are specific to a clinical scenario.

publication date

  • February 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2012.07.030

PubMed ID

  • 22854248

Additional Document Info

start page

  • 201

end page

  • 9

volume

  • 63

number

  • 2